Canopy Growth (CGC) Expected to Announce Quarterly Earnings on Friday

Canopy Growth (NASDAQ:CGC) is projected to release its Q1 2027 results before the market opens on Friday, August 7th. Analysts expect the company to post earnings of ($0.04) per share and revenue of $58.2080 million for the quarter. Investors may visit the the company’s upcoming Q1 2027 earning overview page for the latest details on the call scheduled for Friday, August 7, 2026 at 10:00 AM ET.

Canopy Growth (NASDAQ:CGC) last released its quarterly earnings data on Monday, June 15th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by ($0.11). The firm had revenue of $51.22 million during the quarter, compared to analyst estimates of $53.43 million. Canopy Growth had a negative net margin of 75.27% and a negative return on equity of 26.95%. On average, analysts expect Canopy Growth to post $-0 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Canopy Growth Stock Down 2.8%

Shares of NASDAQ CGC opened at $0.93 on Wednesday. The company has a 50 day simple moving average of $0.97 and a 200 day simple moving average of $1.05. The company has a debt-to-equity ratio of 0.31, a current ratio of 3.34 and a quick ratio of 2.64. Canopy Growth has a 1 year low of $0.84 and a 1 year high of $2.38. The firm has a market cap of $417.61 million, a PE ratio of -1.58 and a beta of 0.81.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded Canopy Growth from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, July 29th. Two investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold”.

Insiders Place Their Bets

In other news, CEO Luc Mongeau sold 135,231 shares of the stock in a transaction that occurred on Wednesday, June 17th. The shares were sold at an average price of $0.97, for a total transaction of $131,174.07. Following the completion of the transaction, the chief executive officer directly owned 1,723,913 shares of the company’s stock, valued at $1,672,195.61. This represents a 7.27% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Christelle Gedeon sold 58,994 shares of the firm’s stock in a transaction on Wednesday, June 17th. The stock was sold at an average price of $0.97, for a total value of $57,224.18. Following the completion of the sale, the insider directly owned 705,506 shares of the company’s stock, valued at $684,340.82. This represents a 7.72% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 224,958 shares of company stock valued at $217,137 in the last 90 days. 0.16% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Jones Financial Companies Lllp lifted its holdings in Canopy Growth by 10,308.3% during the first quarter. Jones Financial Companies Lllp now owns 969,533 shares of the company’s stock valued at $882,000 after purchasing an additional 960,218 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in shares of Canopy Growth by 64.6% in the first quarter. Goldman Sachs Group Inc. now owns 330,278 shares of the company’s stock worth $301,000 after purchasing an additional 129,620 shares in the last quarter. Murchinson Ltd. purchased a new position in shares of Canopy Growth in the second quarter worth about $183,000. Boothbay Fund Management LLC bought a new stake in shares of Canopy Growth in the second quarter valued at approximately $30,000. Finally, Tidal Investments LLC raised its position in shares of Canopy Growth by 31.5% in the second quarter. Tidal Investments LLC now owns 5,033,793 shares of the company’s stock valued at $6,141,000 after purchasing an additional 1,204,530 shares during the period. Institutional investors own 3.33% of the company’s stock.

About Canopy Growth

Canopy Growth Corporation is a leading Canadian cannabis company engaged in the production, distribution and sale of both medical and recreational cannabis products. Headquartered in Smiths Falls, Ontario, the company cultivates a diversified portfolio of offerings that includes dried flower, pre-rolled joints, oils, softgel capsules and edibles. Canopy Growth also markets derivative products such as beverages and wellness formulations under a range of brands, aiming to serve both patient and adult-use markets.

The company operates through multiple subsidiaries, including Tweed Inc, Spectrum Therapeutics and Tokyo Smoke, each targeting distinct consumer segments.